New Delhi, September 3 (HS): Shares of Anlon Healthcare, a manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), made a lackluster debut on the stock exchanges today, leaving IPO investors underwhelmed.

The company’s shares were issued at ₹91 per share in its initial public offering (IPO). On listing day, the stock opened flat at ₹91 on the BSE, while on the NSE it debuted with a modest 1% premium at ₹92.

Post-listing, Anlon Healthcare’s share price continued to trade within a narrow range. By market close, the stock settled at ₹91.66 on the BSE and ₹91.73 on the NSE, giving IPO investors a marginal gain of less than 0.8% on the first day.

The company’s ₹121 crore IPO, which was open for subscription from August 26 to 29, had received an encouraging response from investors, being oversubscribed nearly 7 times. The price band for the issue was fixed at ₹86–91 per share.

Proceeds from the IPO will be used to expand Anlon Healthcare’s manufacturing facilities, repay outstanding borrowings, meet working capital requirements, and fund general corporate purposes.

---------------

Hindusthan Samachar / Jun Sarkar